News

Cystic fibrosis–related diabetes requires different approach


 

EXPERT ANALYSIS FROM THE PAS ANNUAL MEETING

References

“Why are we calling this diabetes? These patients have repeated bouts of acute illness. The CF patient you’re seeing today in the hospital may very well be back in 5 months, and again 2 months after that. It’s a frequent event in these patients, and when their diabetes persists for longer than 48 hours it tends to persist for weeks before their need for insulin goes away until the next time they get sick. But most of these patients spend a substantial amount of time each year hyperglycemic. And most importantly, if you use as your date of diagnosis diabetes that’s present at the time of an acute illness, it correlates with microvascular complications and with mortality. So it establishes a meaningful start point for future risk,” Dr. Moran said.

She reported financial relationships with Novo Nordisk and Vertex.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Class of 2015: New drugs projected to earn billions and billions
MDedge Endocrinology
Stenting before CABG linked to higher mortality for diabetic patients
MDedge Endocrinology
Unrecognized diabetes common in acute MI
MDedge Endocrinology
How to forestall heart failure by 15 years
MDedge Endocrinology
Novel agent lowers LDL more than ezetimibe
MDedge Endocrinology
Testosterone therapy has neutral cardiovascular effects
MDedge Endocrinology
Metformin underprescribed in adults with prediabetes
MDedge Endocrinology
Overweight, but not obese, diabetes patients had lower mortality risks
MDedge Endocrinology
Study evaluates early-life determinants of adolescent adiponectin levels
MDedge Endocrinology
How to code for cystic fibrosis–related diabetes
MDedge Endocrinology